Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Danone Gets Second Time Lucky, Buys Wockhardt's Nutrition Brands That Abbott Had Won And Lost

This article was originally published in PharmAsia News

Executive Summary

HYDERABAD, India - After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. finally managed to sell its growing nutritional business to French food giant Group Danone for reportedly $354 million - a quantum jump from the $130 million that Abbott Laboratories Ltd. had agreed to pay for the same assets exactly two years ago

You may also be interested in...



Deal Buzz: Is Abbott Teaming Up With India’s Biocon To Develop Nutrition Products?

India-based Biocon’s CRO arm Syngene is said to be partnering with Abbott over nutrition products, but neither company will provide details…yet.

Deal Buzz: Is Abbott Teaming Up With India’s Biocon To Develop Nutrition Products?

India-based Biocon’s CRO arm Syngene is said to be partnering with Abbott over nutrition products, but neither company will provide details…yet.

Long Search Ends For Sanofi As It Buys Universal Medicare's Nutraceutical Brands In India

MUMBAI - French drug maker Sanofi's long search for high-growth OTC brands in India finally materialized as it announced the acquisition of Mumbai-headquartered Universal Medicare Pvt. Ltd.'s nutraceutical businesses

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC078788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel